Major Publications in the Critical Care Pharmacotherapy Literature: 2022

• Authors: Payal K. Gurnani, Memorial Hermann The Woodlands Medical Center; Brooke Barlow, Memorial Hermann The Woodlands Medical Center; Bryan Boling, University of Kentucky; Laurence W. Busse, Emory University; Jose Diaz-Gomez, Baylor College of Medicine; Jenna Ford, University of Florida, Gainesville; Gabrielle A. Gibson, Barnes-Jewish Hospital; Ashish K. Khanna, Wake Forest University School of Medicine; Jennifer S. Lee, Mount Sinai West; Ryan M. Ricosecchi, University of Pittsburgh; Katherine M. Spezzano, University of Kentucky; Nathan Thornton, May Clinic, Rochester; Saraschandra Vallabhajosyula, Wake Forest University; Corey J. Witenko, New York-Presbyterian Hospital; Patrick M. Wieruszewski, Mayo Clinic, Rochester
• Journal Title: Critical Care Explorations
• Volume: Volume 5, Number 10
• Publisher: Wolters Kluwer Health, Inc. | 2023-09-22, Pages e0981-None
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.1097/CCE.0000000000000981
• Subjects: Health Sciences, Health Care Management
• Keywords: critical; care; critically ill; pharmacotherapy; review sedation; septic shock

Abstract

OBJECTIVES: A number of trials related to critical care pharmacotherapy were published in 2022. We aimed to summarize the most influential publications related to the pharmacotherapeutic care of critically ill patients in 2022. DATA SOURCES: PubMed/Medical Literature Analysis and Retrieval System Online and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update. STUDY SELECTION: Randomized controlled trials, prospective studies, or systematic review/meta-analyses of adult critically ill patients assessing a pharmacotherapeutic intervention and reporting clinical endpoints published between January 1, 2022, and December 31, 2022, were included in this article. DATA EXTRACTION: Articles from a systematic search and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update were included and stratified into clinical domains based upon consistent themes. Consensus was obtained on the most influential publication within each clinical domain utilizing an a priori defined three-round modified Delphi process with the following considerations: 1) overall contribution to scientific knowledge and 2) novelty to the literature. DATA SYNTHESIS: The systematic search and Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update yielded a total of 704 articles, of which 660 were excluded. The remaining 44 articles were stratified into the following clinical domains: emergency/neurology, cardiovascular, gastroenterology/fluids/nutrition, hematology, infectious diseases/immunomodulation, and endocrine/metabolic. The final article selected from each clinical domain was summarized following a three-round modified Delphi process and included three randomized controlled trials and three systematic review/meta-analyses. Article topics summarized included dexmedetomidine versus other sedatives during mechanical ventilation, beta-blocker treatment in the critically ill, restriction of IV fluids in septic shock, venous thromboembolism prophylaxis in critically ill adults, duration of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia, and low-dose methylprednisolone treatment in severe community-acquired pneumonia. CONCLUSIONS: This concise review provides a perspective on articles published in 2022 that are relevant to the pharmacotherapeutic care of critically ill patients and their potential impact on clinical practice.